New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 27, 2010
14:19 EDTABC, MCK, SNY, HSPRumor: Pharma Distributors move up on speculation of a positive court ruling
Shares of Hospira (HSP), McKesson (MCK) and AmerisourceBergen (ABC) are moving higher on conjecture that a District Court declared Sanofi's patents invalid, clearing the way for generic Taxotere.
News For HSP;MCK;ABC;SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 6, 2015
11:43 EDTHSPHospira comments on FDA approval of first biosimilar in the U.S.
Hospira (HSP) said in a statement that it "applauds Sandoz (NVS) and the U.S. FDA on today's FDA approval of the first biosimilar in the United States. This is a watershed moment for improving patient access to safe, effective and more affordable biologic medicines. As a global provider of biosimilars, Hospira has seen first-hand the positive impact of biosimilars in other countries, and we are a proud participant in these early stages of the development of a pathway for these medicines in the United States." "Biosimilars represent a transformational opportunity to improve patient access and provide much-needed financial relief to the U.S. healthcare system," said Sumant Ramachandra, M.D., Ph.D., senior VP, Research & Development and Medical & Regulatory Affairs, and chief scientific officer, Hospira. "This approval is good news for the entire healthcare system and brings us one step closer to making these important medications available for the patients who need them. With two biosimilar applications currently under review by the U.S. FDA, Hospira is committed to bringing more affordable biologic medicines to patients in the United States. We look forward to continuing to partner with the FDA on the approval pathway for our biosimilars, so that more and more patients and healthcare providers have access to the benefits of biosimilars."
March 4, 2015
11:09 EDTSNYSanofi, Novartis, Shire may be weighing Genfit acquisition, Bloomberg says
Subscribe for More Information
07:30 EDTMCKMcKesson management to meet with UBS
Meeting to be held in Toronto on March 4 hosted by UBS.
March 3, 2015
11:46 EDTSNYLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:24 EDTABCAmerisourceBergen can mitigate loss of PharMerica deal, says RBC Capital
Subscribe for More Information
March 2, 2015
08:53 EDTSNYNon-profit gives lukewarm review to MannKind inhaled insulin, TheStreet says
Subscribe for More Information
February 27, 2015
16:15 EDTHSPHospira: No Form 483 observations issued after inspection of Costa Rica facility
Subscribe for More Information
07:22 EDTSNYSanofi reports positive opinion from CHMP for Toujeo
Sanofi announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has issued a positive opinion recommending the approval of Toujeo, a next-generation basal insulin for the treatment of adults with type 1 and type 2 diabetes. Toujeo has demonstrated a more stable and a prolonged glycemic control that lasts beyond 24 hours compared with Lantus with low within-individual, within-day blood sugar variability. The European Commission is expected to make a final decision on granting marketing authorization for Toujeo in the EU in the coming months. Toujeo was approved by the FDA and is under review by other regulatory authorities around the world. Once approved, Toujeo will be available in the Toujeo SoloSTAR, a disposable prefilled pen which contains 450 insulin units, and it has a maximum single injection dose of 80 IU.
February 26, 2015
14:03 EDTABCGabelli liquidates 7.69% stake in MWI Veterinary Supply
As a result of the completion of the acquisition of the company by the AmerisourceBergen (ABC), Gabelli no longer has beneficial ownership of any of the company's shares.
09:41 EDTHSPHospira launches generic Remicade, WSJ says
Subscribe for More Information
05:32 EDTSNYSanofi receives FDA approval of once-daily basal insulin Toujeo
Sanofi announced that the FDA approved Toujeo, a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is expected to be available in the U.S. at the beginning of Q2. The approval of Toujeo was based on FDA review of results from the EDITION clinical trial program, which was comprised of a series of international Phase III studies evaluating the efficacy and safety of Toujeo in more than 3,500 adults from broad and diverse diabetes populations.
February 25, 2015
20:05 EDTSNYSanofi receives FDA approval of once-daily basal insulin Toujeo
Subscribe for More Information
February 24, 2015
15:18 EDTABCAmerisourceBergen completes acquisition of MWI Veterinary Supply
AmerisourceBergen (ABC) announced the completion of its acquisition of MWI Veterinary Supply (MWIV). At the effective time of the merger, all remaining shares of MWI common stock not tendered into the tender offer were converted into the right to receive $190 in cash, without interest and less any applicable withholding taxes, which is the same price that was paid in the tender offer. As a result of the transaction, MWI has become a wholly owned subsidiary of AmerisourceBergen.
07:36 EDTABCAmerisourceBergen completes tender offer for MWI Veterinary Supply shares
AmerisourceBergen Corporation (ABC) has successfully completed its tender offer to purchase all outstanding shares of MWI Veterinary Supply (MWIV) common stock for $190.00 per share in cash, without interest and less any applicable withholding taxes. The tender offer expired at 11:59 p.m., New York City time, on February 23. As of the expiration of the tender offer, 10,096,484 shares had been validly tendered and not validly withdrawn, representing approximately 78.1% of MWI's outstanding shares of common stock on a fully diluted basis. All conditions to the tender offer have been satisfied, and AmerisourceBergen has accepted for payment and will promptly pay the depositary for all validly tendered shares. AmerisourceBergen expects to complete the acquisition of MWI later today through a merger without a vote or meeting of MWI's stockholders.
February 22, 2015
21:52 EDTABCVascular Solutions to replace MWI Veterinary Supply in S&P 600 as of 2/23 close
S&P 500 constituent AmerisourceBergen (ABC) is acquiring MWI Veterinary Supply (MWIV) in a transaction expected to be completed soon.
February 20, 2015
07:08 EDTSNYAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use